Happy to see online Nature Reviews Urology our forward thinking review on chromosomal instability (CIN) in #prostatecancer it was fun to write this piece MayoClinicBMB Mayo Clinic Urology Mayo Clinic Comprehensive Cancer Center
rdcu.be/dxIxA

Today ASCO #GU24 don't miss Fabrice Lucien, PhD Poster #H20 , 11:30 PST
Prognostic value of PSMA-extracellular vesicles in oligometastatic castration-sensitive prostate cancer treated with stereotactic ablative radiotherapy: A multi-center observational study.
#ProstateCancer
Ali Arafa

Mayo Clinic Hematology-Oncology Fellowship Saurabh Zanwar One of the best physicians, scientists, and a dear friend. Congratulations!!!

FINALLY - what I have been looking forward to prove for 20 years: the detection performance of DRE for PCa is so weak that we can forego this exam. Hope the guidelines take this evidence to stop recommending DRE for PCa screening/early detection.
sciencedirect.com/science/articl…

Fond memories of a chilly December evening... Thanks so much IJROBP - The Red Journal for allowing me to share this special event.

Thank you, UroToday.com for highlighting our work and for all you do to shed light on the fight against prostate cancer! Emmanuel Antonarakis Mayo Clinic Comprehensive Cancer Center
urotoday.com/video-lectures…

The clinical trials process has become so convoluted! Walter Stadler succinctly breaks down a $100B industry in 7 minutes, challenging us to stop doing stupid stuff.

✅Ask simple questions
✅Ask only what needs to be done, question 'but X requires this'
✅KISS

#DAVABroadmoorGU

Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation | Science Advances science.org/doi/full/10.11…

Biblically correct ophthalmologist?

New #ETCTN #prostatecancer #clinicaltrial activation: (10603), “Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer’, led by Jake Orme MD PhD of Mayo Clinic Comprehensive Cancer Center. buff.ly/3rUxMxg #NCICTEP

A Mayo Clinic Urology paper just published Cell Reports Medicine found a new therapeutic vulnerability of lethal prostate cancer. Dr. Veronica Rodriguez-Bravo team uncovered how a tumor’s high chromosomal instability (CIN) can be turned against itself. bit.ly/3XSKvLh #ProstateCancer #Urology

Mayo Clinic joins the Union for International Cancer Control and other global organizations on #WorldCancerDay , Feb. 4, to close the gap and reduce inequities in cancer care.

Here are five ways to help reduce your risk of cancer: mayocl.in/3XTQjF7 Mayo Clinic Comprehensive Cancer Center

Great work from Joanina Gicobi, Ph.D. (She/Her) et al on the metabolic features of resilient CD8-T cells. Malic enzyme 1 (ME1) is a critical factor for ROS homeostasis and cytotoxic function #Immunometabolism #cd8tcells

Alan Bryce presenting first results of the positive TRITON3 study of rucaparib in refractory mCRPC!

Treatments for #prostatecancer are rapidly advancing. With an integrated genitourinary practice, experts Mayo Clinic Comprehensive Cancer Center have the size and scope of practice needed to drive the field forward with theranostics, #genomics , 3D imaging and modeling, and more.
mayocl.in/3LiVn05

Excited about our review of radiotherapy in oligometastatic prostate cancer and its implications for immunotherapy and combination therapies in the future.
sciencedirect.com/science/articl…

Amazing colleagues and friends Mayo Clinic Hematology-Oncology Fellowship Mayo Clinic